Lexon Pharmaceuticals (Ireland) Ltd
- A05 - Terapia biliar y hepática
- URSOFALK capsule, hard 250 mg
- A10 - Antidiabéticos
- LAMZARIN prolonged-release tablet 30 mg
- LAMZARIN prolonged-release tablet 60 mg
- C01 - Terapia cardíaca
- IVABRADINE LEXON film-coated tablet 5 mg
- IVABRADINE LEXON film-coated tablet 7.5 mg
- C03 - Diuréticos
- ALDACTONE LEXON film-coated tablet 25 mg
- C10 - Agentes modificadores de los lípidos
- EZETIMIBE LEXON tablet 10 mg
- D01 - Antifúngicos para uso dermatológico
- TROSYL medicated nail lacquer 28%
- G04 - Urológicos
- VESOMNI modified-release tablet 0.4 mg+6 mg
- J05 - Antivirales de uso sistémico
- VALTREX film-coated tablet 500 mg
- M01 - Antiinflamatorios y antirreumáticos
- CELECOXIB LEXON capsule, hard 100 mg
- CELECOXIB LEXON capsule, hard 200 mg
- N03 - Antiepilépticos
- TOPAMAX film-coated tablet 100 mg
- TRILEPTAL film-coated tablet 300 mg
- TRILEPTAL oral suspension 60 mg/ml
- ZARONTIN syrup 250 mg/5 ml
- N06 - Psicoanalépticos
- TRAZODONE HYDROCHLORIDE LEXON oral solution 50 mg/5 ml
- ZYBAN prolonged-release tablet 150 mg
- S01 - Oftalmológicos
- ALPHAGAN LEXON eye drops, solution 0.2%